Volume 5, Number 4—August 1999
THEME ISSUE
Bioterrorism
Perspective
Vaccines, Pharmaceutical Products, and Bioterrorism: Challenges for the U.S. Food and Drug Administration
Table
Proposed activities of the U.S. Food and Drug Administration to counter bioterrorism
| 1. Enhancing the expeditious development and licensure of new vaccines and biological therapeutics through research and review activities—anthrax vaccine and antisera to botulinum toxin, for example. |
| 2. Enhancing the timeliness of application reviews of new drugs and biological products and new uses of existing products. |
| 3. Participating in the planning and coordination of public health and medical response to a terrorist attack involving a biological or chemical agent(s). |
| 4. Participating in the development of rapid detection and decontamination for agents of bioterrorism such as Clostridium botulinum toxins, Yersinisa pestis, Bacillus anthracis. |
| 5. Ensuring the safety of regulated foods, drugs, medical devices, and biological products; arrange for seizure and disposal of affected products. |
| 6. Developing techniques for detection of genetic modifications of microorganisms to make them more toxic or antibiotic-or vaccine-resistant. |
| 7. Rapidly determining a microbe's sensitivity to drug therapy. |
| 8. Determining the mechanism of replication and pathogenicity or virulence of identified organisms including elements that can be transferred to other organisms to circumvent detection, prevention, or treatment |
| 9. Enhancing adverse product reporting surveillance capabilities. |
Medline indexes "Am J Public Health" but cannot find a listing for the reference 2 "Brachman, Gold, Plotkin, Fekety, Werrin, Ingraham, 1962". Please check the reference for accuracy.
Page created: December 13, 2010
Page updated: December 13, 2010
Page reviewed: December 13, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.